Scholar

Hans Clevers

Johannes (Hans) Carolus Clevers is a Dutch molecular geneticist, cell biologist and stem cell researcher. He became the Head of… more

Hans Clevers
H-index: 232
Biology 78%
Medicine 16%
hansclevers.bsky.social
thecleverslab.bsky.social
4/4 This work was a true team effort between @amolf-nl.bsky.social, IHB Basel, and the @Hubrechtinstitute.bsky.social — led by @danielkrueger.bsky.social and Kasper Spoelstra. Huge thanks to all collaborators for making it possible.
hansclevers.bsky.social
11/11Gut homeostasis is not passive crowd control. It’s an active, force-regulated process. Cells constantly test each other’s strength; those that fail the tug-of-war extrude.A collaboration between the @hubrechtinstitute.bsky.social , @amolf-nl.bsky.social & @IHB lead by @danielkrueger.bsky.social
hansclevers.bsky.social
10/11 Disease link: In EpCAM loss (tufting enteropathy), hyperactive myosin caused excessive extrusion, growth defects, and tissue disruption. Too much force destabilizes the barrier. Mixing mutant & WT cells made healthy cells extrude. Myosin inhibition rescued this effect.
hansclevers.bsky.social
9/11 With point ablations at the base, we intentionally weakened individual cells. Within minutes, these cells extruded - loss of tension likely triggers extrusion.
hansclevers.bsky.social
8/11 Local optogenetic activation of cells on villus substrates, creating boundaries between highly- and less-contractile cells caused preferential extrusion on the weaker side. In mosaic organoids, less contractile cells were consistently eliminated.
"Weaker" less contractile cells that can not sustain the tension level of their neighbours in the tissue preferentially extruded.
hansclevers.bsky.social
7/11 Optogenetics let us induce contractility with blue light and spatial precision. Extrusion rates jumped up upon activation, showing that globally increased tension directly drives extrusion.
hansclevers.bsky.social
6/11 A basal actomyosin network drives epithelial tension. On hydrogel villus substrates (generated @ IHB, Basel), resembling the in vivo topology, we saw pulsatile contractions—one cell contracts, neighbors expand. A tissue-wide tug-of-war.
hansclevers.bsky.social
5/11 Using CRISPR-generated myosin reporters, we first observed myosin increasing in extruding cells, together with a synchronized response in their neighbors—explaining extrusion dynamics as a coordinated process.
hansclevers.bsky.social
4/11 Are villus tips—where extrusion peaks—compressed by crowding? At the Hubrecht, laser ablation revealed they are under tension, not compression. That tension sets the stage for extrusion.
Laser ablation at the villus tip revealed that the tissue is under tension and cells are not under compression.
hansclevers.bsky.social
3/11 Using long-term live imaging & tracking (with @amolf-nl.bsky.social), we followed hundreds of extrusion events. Most villus cells extruded alive, not apoptotic. Extrusion did not correlate with density.
hansclevers.bsky.social
2/11 The intestinal lining renews every few days. Old cells are shed by extrusion—a process essential for barrier integrity and linked to diseases like IBD. But what actually triggers extrusion in mammals was unclear.

Reposted by: Hans Clevers

thecleverslab.bsky.social
4/4 This work was a true team effort between @amolf-nl.bsky.social, IHB Basel, and the @Hubrechtinstitute.bsky.social — led by @danielkrueger.bsky.social and Kasper Spoelstra. Huge thanks to all collaborators for making it possible.
hansclevers.bsky.social
Brain diseases are tough to treat because of the blood-brain barrier. For decades, it stumped drug delivery. At Roche pRED, we challenged that! Our Brainshuttle™ technology safely transports drugs across, opening new doors for CNS therapies. Learn more: www.roche.com/stories/clev...
Roche | Clever delivery
Brainshuttle™ technology by Roche enables effective medicine delivery across the blood-brain barrier, revolutionising CNS disease treatment and patient care.
www.roche.com

Reposted by: Hans Clevers

Reposted by: Hans Clevers

Reposted by: Hans Clevers

Reposted by: Hans Clevers

Reposted by: Hans Clevers

hansclevers.bsky.social
Exciting #organoids meeting in Glasgow, just after the summer!
hansclevers.bsky.social
🔬 Developing next-generation Antibiotics: @Roche we are pioneering the discovery and development of novel antibiotics that can fight resistant bacteria, aiming for future generations to have effective treatments. Visit our #AMR hub:https://www.roche.com/stories/antibiotics

Reposted by: Hans Clevers

Reposted by: Hans Clevers

hansclevers.bsky.social
@NatureMedicine
invited me to reflect on leading research in academia vs. industry. In the end, all -academia, biotech & pharma- is needed to translate scientific breakthroughs into scalable treatments. rdcu.be/elPt8
@_hubrecht
@Roche
Parallel worlds in pharma and academia
Nature Medicine - Pharma and academia require different ways of working and speaking, but teamwork always wins.
rdcu.be

References

Fields & subjects

Updated 1m